Singapore markets closed

Co-Diagnostics, Inc. (C97.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
12.50-1.00 (-7.41%)
At close: 8:07AM CET
Full screen
Previous close13.50
Open12.50
Bid0.00 x 2075500
Ask0.00 x 1250000
Day's range12.50 - 12.50
52-week range6.05 - 29.40
Volume2,105
Avg. volume803
Market cap319.894M
Beta (5Y monthly)-1.82
PE ratio (TTM)11.14
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Why Co-Diagnostics Stock Is Shooting Higher Today
    Motley Fool

    Why Co-Diagnostics Stock Is Shooting Higher Today

    Co-Diagnostics (NASDAQ: CODX), considered a coronavirus stock because of its COVID-19 testing products, was up by nearly 9% in midafternoon trading on Wednesday. The test, which has Emergency Use Authorization from the Food and Drug Administration, harnesses Co-Diagnostics' patented testing technology. In Walgreens' announcement, the company quoted Clinical Reference Laboratory CEO Robert Thompson as saying that the test "demonstrated highly accurate results with 100% sensitivity and specificity in its FDA EUA filing."

  • Co-Diagnostics Names New CFO and CSO
    Motley Fool

    Co-Diagnostics Names New CFO and CSO

    Tuesday was a busy day in the upper managerial ranks of Co-Diagnostics (NASDAQ: CODX). The molecular diagnostics specialist appointed both a new CFO and a new chief science officer (CSO). The former is Brian Brown, who replaces current office holder Reed Benson.

  • 3 Stocks That Are Absurdly Cheap Right Now
    Motley Fool

    3 Stocks That Are Absurdly Cheap Right Now

    Telephone and Data Systems (NYSE: TDS), Tri Pointe Homes (NYSE: TPH), and Co-Diagnostics (NASDAQ: CODX) all have modest share prices yet stand on solid ground. The company did an excellent job of keeping costs down, so net income was $254 million, up 92% compared to the same period in 2019.